General Information


DRAVP ID  DRAVPe02108

Peptide Name   SB2

Sequence  GSRRPVPIIYCNRRTGRCQRI

Sequence Length  21

UniProt ID  None  

Taxon ID  None 

Source  De novo designed

Validation   Experimentally validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Found



Activity Information


Target Organism  HIV-1IIIB, HSV-2MS

Assay  Anti-HIV assays

Activity 

  • Ref:Not Available]HIV,HSV: EC50=3.33 µg/ml in CEM-SS cells, >100 µg/ml in Vero cells (HSV)

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • TC50:>100 µg/ml in CEM-SS Cells, >100 µg/ml in Vero Cells (HSV)

Binding Target  Not Found

Mechanism  Not Available



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Not included yet

C-terminal Modification  Not included yet

Other Modification  C11-C18 disulfide linkage

Stereochemistry  L



Physicochemical Information


Formula  C104H181N35O27S2

Absent amino acids  ADEHMFWOU

Common amino acids  RK

Mass  2417.92

Pl  10.47

Basic residues  7

Acidic residues  0

Hydrophobic residues  16

Net charge  7

Boman Index  1.24

Hydrophobicity  -0.776

Aliphatic Index  69.52

Half Life 

  •     Mammalian:30 hours
  •     Yeast:>20 hours
  •     E.coli:>10 hours

Extinction Coefficient cystines  1615

Absorbance 280nm  0.668

Polar residues  22



Literature Information


Literature 1

Title   De Novo Design of Antiviral and Antibacterial Peptides with Varying Loop Structures

Pubmed ID   Not Avaialbe

Reference   Reginald et al. J AIDS Clinic Res 2011, S10

Author   Wang G, Watson KM, Mishra B, Lushnikova T, Buckheit RW Jr. 2019

DOI   10.4172/2155-6113.S2-011